We also obtained a similar result by treating the HemSCs and cell implants with bevacizumab (see supplementary material, Figure S7A), suggesting the importance of VEGF‐A signalling in the growth and angiogenesis of this IH model. The gene discussed is VEGFA; the disease is isolated hemihyperplasia.